Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Archives of Psychiatry and Clinical Neuroscience
Published in: European Archives of Psychiatry and Clinical Neuroscience 2/2011

01-03-2011 | Original Paper

The illness and everyday living: close interplay of psychopathological syndromes and psychosocial functioning in chronic schizophrenia

Authors: Daniela Schaub, Martin Brüne, Elisabeth Jaspen, Frank-Gerald Pajonk, Hans-Werner Bierhoff, Georg Juckel

Published in: European Archives of Psychiatry and Clinical Neuroscience | Issue 2/2011

Login to get access

Abstract

The interaction of psychopathological states and psychosocial functioning determine the long-term course of schizophrenia and its treatment. To be able to achieve this interplay better, exact assessment of psychosocial functioning is needed besides measurement of psychopathology. Using the Personal and Social Performance (PSP) Scale, examination of the association between psychosocial functioning and psychopathology was conducted in a sample of 103 patients with chronic schizophrenia. Rating instruments were in addition Global Assessment of Functioning Scale and Social and Occupational Functioning Assessment Scale, as well as Positive and Negative Syndrome Scale (PANSS), Clinical Global Impression Scale, and Mini-ICF-APP-Rating for Mental Disorders (Mini-ICF-APP). Besides good psychometric properties for the PSP scale in this chronic sample, we found, as expected, significant associations between the two relevant outcome domains: results showed significant negative correlations between PSP and PANSS. Findings prove the close interplay between social functioning and psychopathology in the chronic course of schizophrenia.
Literature
1.
Angermeyer MC, Holzinger A, Matschinger H (1999) Quality of life—what it means to me. Results of a survey among schizophrenic patients. Psych Prax 26:56–60
2.
Burns T, Patrick D (2007) Social functioning as an outcome measure in schizophrenia studies. Acta Psych Scand 116:403–418CrossRef
3.
Dantendorfer K, Swoboda H (2006) Long-term treatment of psychophrenic psychoses. J Neurol Neurochir Psychiatr 7:28–31
4.
Ertugrul A, Ulug B (2002) The influence of neurocognitive deficits and symptoms on disability in schizophrenia. Acta Psych Scand 105:196–201CrossRef
5.
Franz M (2006) Possibilities and limitations of the use of quality of life as outcome-indicator in schizophrenic patients. Psych Prax 33:317–322CrossRef
6.
Ginsberg DL, Schooler NR, Buckley PF, Harvey PD, Weider PJ (2005) Optimizing treatment of schizophrenia. Enhancing affective/cognitive and depressive functioning. CNS Spectr 10:1–13PubMed
7.
Guy W (1976) Clinical global impressions. In: ECDEU assessment manual for psychopharmacology. National Institute for Mental Health, Rockville, pp 218–222
8.
Hofer A, Rettenbacher MA, Widschwendter CG, Kemmler G, Hummer M, Fleischhacker WW (2006) Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder. Eur Arch Psychiatry Clin Neuroscience 256(4):246–255CrossRef
9.
Juckel G, Schaub D, Fuchs N, Naumann U, Uhl I, Witthaus H et al (2008) Validation of the personal and social performance (PSP) scale in a German sample of acutely ill patients with schizophrenia. Schiz Res 104:287–293CrossRef
10.
Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schiz Bull 13:261–276
11.
Kilian R (2006) For and against: is quality of life a meaningful indicator of outcome? Psych Prax 33:312–314CrossRef
12.
Lambert M, Naber D (2004) Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life. CNS Drugs 18:5–17PubMedCrossRef
13.
Linden M, Baron S (2005) The Mini-ICF-APP-Rating for Mental Disorders (Mini-ICF-APP-P). A short instrument for the assessment of disabilities in mental disorders. Rehabilitation 44:144–151PubMedCrossRef
14.
McGurk SR, Meltzer HY (2000) The role of cognition in vocational functioning in schizophrenia. Schiz Res 45:175–184CrossRef
15.
Meyer T, Franz M (2006) Concepts of quality of life in patients with schizophrenia. The relationship to their quantitative evaluation of quality of life. Psych Prax 33:344–349CrossRef
16.
Morosini PL, Magliano L, Brambilla L, Ugolini S, Pioli R (2000) Development, reliability and acceptability of a new version of the DSM-IV social and occupational functioning assessment scale (SOFAS) to assess routine social functioning. Acta Psych Scand 1001:323–329
17.
Nasrallah HA, Targum SD, Tandon R, McCombs JS, Ross R (2005) Defining and measuring clinical effectiveness in the treatment of schizophrenia. Psych Serv 56:273–282CrossRef
18.
Patrick D, Morosini P, Rothman M (2006) Personal and social performance scale: reliability, validity and ability to detect change in patients with acute schizophrenia. Poster no. NR416 presented at APA, Toronto, Canada
19.
Saß H, Wittchen HU, Zaudig M (1996) Diagnostic and statistical manual of mental disorders. 4th edn. (DSM-IV). Göttingen Hogrefe
20.
Schmid R, Neuner T, Cording C, Spiessl H (2006) Schizophrenic patients’ quality of life—association with coping, locus of control, subjective well-being, satisfaction and patient-judged caregiver burden. Psych Prax 33:337–343CrossRef
21.
Van der Gaag M, Hoffman T, Remijsen M, Hijman R, de Haan L, van Meijel B et al (2006) The five-factor model of the positive and negative syndrome scale II: a ten-fold cross-validation of a revised model. Schiz Res 85:280–287CrossRef
22.
Van Os J, Gilvarry C, Bale R, van Horn E, Tattan T, White I et al (1999) To what extent does symptomatic improvement result in better outcome in psychotic illness? Psychol Med 29:1183–1195PubMedCrossRef
23.
WHO (1995) International diagnoses checklist for ICD-10 (IDCL). Bern Hans, Huber Verlag
24.
Wittorf A, Wiedemann G, Buchkremer G, Klingberg S (2008) Prediction of community outcome in schizophrenia 1 year after discharge from inpatient treatment. Eur Arch Psychiatry Clin Neurosci 258(1):48–58PubMedCrossRef
Metadata
Title
The illness and everyday living: close interplay of psychopathological syndromes and psychosocial functioning in chronic schizophrenia
Authors
Daniela Schaub
Martin Brüne
Elisabeth Jaspen
Frank-Gerald Pajonk
Hans-Werner Bierhoff
Georg Juckel
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
European Archives of Psychiatry and Clinical Neuroscience / Issue 2/2011
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-010-0122-1

Other articles of this Issue 2/2011

European Archives of Psychiatry and Clinical Neuroscience 2/2011 Go to the issue

Short Communication

Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder

Original Paper

Postmortem proteomic analysis in human amygdala of drug addicts: possible impact of tubulin on drug-abusing behavior

Editorial

The functional sequelae of schizophrenia: consequences of long-term pharmacotherapy and the neurobiology of addiction

Original Paper

Patients’ attitudes toward side effects of antidepressants: an Internet survey

Original Paper

Attention to emotion: auditory-evoked potentials in an emotional choice reaction task and personality traits as assessed by the NEO FFI

Original Paper

S100B and homocysteine in the acute alcohol withdrawal syndrome